These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26988917)

  • 1. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
    Lee JY; Kim HJ; Rho SB; Lee SH
    Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
    Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
    Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACAP inhibits tumor growth and interferes with clusterin in cervical carcinomas.
    Lee JH; Lee JY; Rho SB; Choi JS; Lee DG; An S; Oh T; Choi DC; Lee SH
    FEBS Lett; 2014 Dec; 588(24):4730-9. PubMed ID: 25451228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
    Zhang B; Liu ZM; Hao FG; Wang M
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
    Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.
    Ma G; Cai H; Gao L; Wang M; Wang H
    World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
    Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
    Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
    Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
    J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.
    Li N; Zoubeidi A; Beraldi E; Gleave ME
    Oncogene; 2013 Apr; 32(15):1933-42. PubMed ID: 22689054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
    Cuesta R; Berman AY; Alayev A; Holz MK
    J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F.
    Esteves P; Dard L; Brillac A; Hubert C; Sarlak S; Rousseau B; Dumon E; Izotte J; Bonneu M; Lacombe D; Dupuy JW; Amoedo N; Rossignol R
    Oncogene; 2020 Jan; 39(3):617-636. PubMed ID: 31527668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.
    Shi J; Kahle A; Hershey JW; Honchak BM; Warneke JA; Leong SP; Nelson MA
    Oncogene; 2006 Aug; 25(35):4923-36. PubMed ID: 16532022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
    Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
    Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.
    Prochnow H; Gollan R; Rohne P; Hassemer M; Koch-Brandt C; Baiersdörfer M
    PLoS One; 2013; 8(9):e75303. PubMed ID: 24073260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eIF3f depletion impedes mouse embryonic development, reduces adult skeletal muscle mass and amplifies muscle loss during disuse.
    Docquier A; Pavlin L; Raibon A; Bertrand-Gaday C; Sar C; Leibovitch S; Candau R; Bernardi H
    J Physiol; 2019 Jun; 597(12):3107-3131. PubMed ID: 31026345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
    Kadam R; Harish M; Dalvi K; Teni T
    Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
    Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
    Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
    Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
    Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
    Klokov D; Leskov K; Araki S; Zou Y; Goetz EM; Luo X; Willson D; Boothman DA
    Oncogene; 2013 Jan; 32(4):479-90. PubMed ID: 22391565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
    Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.